Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

Midsona - Top-line recovery around the corner

01 juli 2026

<a id="bm-comp-c7725b1e-2190-41a4-83d2-a89b70aea75a" name="bm-comp-c7725b1e-2190-41a4-83d2-a89b70aea75a" class="BMCustomAnchor"></a><table><tr><td bm-component-id="c7725b1e-2190-41a4-83d2-a89b70aea75a" style="vertical-align: top; width:100.000000%;"><ul><li>Q2e: 1% organic growth and 4% EBITA margin</li><li>Limited estimate changes</li><li>Trading at NTM EV/EBITA of 10x</li></ul></td></tr></table><a id="bm-comp-56574a24-f33d-40b1-a799-8e6af2bd33ec" name="bm-comp-56574a24-f33d-40b1-a799-8e6af2bd33ec" class="BMCustomAnchor"></a><table><tr><td bm-component-id="56574a24-f33d-40b1-a799-8e6af2bd33ec" style="vertical-align: top; width:100.000000%;"><h3 class="bm-h3">Q2e: back to growth</h3><p style="text-align:left;">We anticipate organic growth of 1% in Q2'26e, implying sales of SEK 885m and EBIT of SEK 33m, for a margin of 3.8%. The organic growth, coupled with a 1.3% M&amp;A contribution and a 0.2% FX effect, puts top-line growth at 2.3%. This would imply the first quarter with positive growth since Q1'25, and we highlight that comps are relatively light but that this also stems from sequential underlying improvements. We expect a slightly lower GM q-o-q (28.7% vs. 29.8%), on assumed higher COGS on raw material prices. The Q1 report commented on a shift in the Nordics, where management expected some volumes that typically land in Q1, to land in Q2, which we also believe will slightly support the quarter.</p><h3 class="bm-h3" style="text-align:left;">What to look for in the Q2 report</h3><p style="text-align:left;">We make limited revisions to our Q2 estimates, increasing '26e-'28e sales and adj. EBIT by ~1% and ~2% p.a., respectively. The majority of changes stem from updated FX movements. We are excited to see the first quarter with Risenta in the figures, and hope for more colour on how physically moving the production will affect earnings. We also expect a decision on the long-term plan for Spain, as this was communicated in the Q1 report. In terms of growth, we look for updates regarding B2B sales in the Nordics, as the termination of unprofitable contracts has weighed on growth for several quarters.</p><h3 class="bm-h3" style="text-align:left;">Implied valuation and new LTIP</h3><p>Based on our revised estimates, the company is trading at ~10x-9x '26e-'27e adj. EV/EBITA, which is ~55-45% below current peer multiples at 15x-14x. We note that peers are in turn trading ~4% above the 10-year historical median of ~14x NTM EV/EBITA. We also note that Midsona has launched a LTIP, with payouts geared 90% to EPS growth ('26-'28) and 10% to emissions reduction, capped at ~1.8% dilution and an estimated P&amp;L cost of SEK 16-50m depending on outcome.</p></td></tr></table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-07-24 Cavotec - Low-margin legacy orders weigh on Q2 Cavotec Analys
2026-07-24 Cavotec - P&M order momentum sustained Cavotec Analys
2026-07-22 Inission - Strong trend to continue Inission Analys
2026-07-22 SinterCast - Q2 still tough, but we see tailwinds... SinterCast Analys
2026-07-22 Medicover - No symptoms of surprise in Q2 Medicover Analys
2026-07-22 Ework Group - Cautious optimism Ework Group Analys
2026-07-22 Donkey Republic - Helsinki deal offers further de... Donkey Repu.. Analys
2026-07-22 Medicover - In line report, reiterated targets Medicover Analys
2026-07-21 Embellence Group - Broad progress in the DTC stra... Embellence .. Analys
2026-07-21 Eltel - Earnings improve, but less than we hoped Eltel Analys
2026-07-21 CTT Systems - Getting closer to lift-off CTT Systems Analys
2026-07-21 CTT Systems - Better Q2 and OK FY'26 guidance on ... CTT Systems Analys
2026-07-21 Ework Group - Order intake turns the corner Ework Group Analys
2026-07-21 Embellence Group - Sales miss, margins resilient Embellence .. Analys
2026-07-20 Studsvik - DRPS turns, Scandpower awaits H2 Studsvik Analys
2026-07-20 Qliro - NCI miss, but TPV growth still healthy Qliro Analys
2026-07-20 Ferronordic - Positioning itself for a strong H2 Ferronordic Analys
2026-07-19 Prevas - Organic recovery delayed further Prevas Analys
2026-07-19 Ovzon - Ramping costs now for bigger wins later Ovzon Analys
2026-07-19 Alligo - Finland again ahead of plan in a solid Q2 Alligo Analys